PHIO
PHIOinsider_universeEverything we've seen
- ▣Nov 20, 7:00 PMjournalstop
Agent 21 — Insider Cluster closed long 6,296 @ $0.65 (-$756.78)
Stop hit: close $0.65 ≤ stop $0.71
- ✓Nov 13, 6:16 PMdecisionacted
Agent 21 — Insider Cluster — buy
Insider cluster (3 insiders, $46K total, 2d old). Bought 6296sh @ $0.77, stop $0.71, target $0.96, 90d horizon.
- ▢Nov 12, 7:00 PMjournal
Agent 21 — Insider Cluster opened long 6,296 @ $0.77
- ❖Nov 12, 7:00 AMnewsvia finnhub
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Highlighting Phio's Differentiated, Paradigm-Shifting Treatment Approach for Skin CancerLive Presentation and Q&A: Wednesday, November 18, 2026 2 PM EDTKing of Prussia, Pennsylvania--(Newsfile Corp. - November 12, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of...
- ▣Oct 12, 8:00 PMjournalstop
Agent 21 — Insider Cluster closed long 4,979 @ $0.92 (-$398.32)
intraday stop sweep
- ❖Oct 12, 8:35 AMnewsvia finnhub
OTC Markets Group Announces Third Annual Global Markets Forum Presentations Now Available On Demand
View presentations from European and Canadian public growth companies following the October 7–8 eventNEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the third annual Global Markets Forum, held October 7–8, 2026, are now available for on-demand viewing. The event was presented in partnership with Aquis Stock Exchange, BME, Canadian Securities Exchange (CSE), OTC Markets Group, and
- ❖Oct 6, 7:00 AMnewsvia finnhub
Phio Pharmaceuticals to Present at The Global Markets Virtual Forum October 8, 2026
Phio invites individual and institutional investors as well as advisors and analysts, to attend online at www.VirtualInvestorConference.comKing of Prussia, Pennsylvania--(Newsfile Corp. - October 6, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary INTASYL® siRNA gene-silencing platform, today announced that Robert Bitterman, President and Chief Executive Officer, will present Phio's INTASYL® siRNA...
- ❖Oct 5, 8:35 AMnewsvia finnhub
OTC Markets Group Announces Agenda for Third Annual Global Markets Forum, October 7th & 8th
Two-day hybrid event will feature presentations from European and Canadian public growth companies, executive insights, and one-on-one investor meetingsNEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the third annual Global Markets Forum, taking place October 7–8, 2026, in partnership with Aquis Stock Exchange, BME, Canadian Securities Exchange (CSE), OTC Markets Group, and SIX Swiss Exch
- ❖Oct 5, 7:00 AMnewsvia finnhub
Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference
Highlighting its Proprietary INTASYL siRNA Therapeutic Platform and Development Update for Lead PH-762 Program in Cutaneous Squamous Cell CarcinomaKing of Prussia, Pennsylvania--(Newsfile Corp. - October 5, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary INTASYL® siRNA gene-silencing platform, today announced that it has accepted the invitation to present at the National Investment Banking...
- ✓Oct 1, 7:16 PMdecisionacted
Agent 21 — Insider Cluster — buy
Insider cluster (3 insiders, $10K total, 2d old). Bought 4979sh @ $1.00, stop $0.92, target $1.25, 90d horizon.
- ▢Sep 30, 8:00 PMjournal
Agent 21 — Insider Cluster opened long 4,979 @ $1.00